Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
08/2000
08/23/2000EP0640072B1 Derivatives of pyridine as hydroxylase and lyase inhibitors
08/23/2000CN1264427A Osteoprotegernin binding proteins and receptors
08/23/2000CN1264426A Ligand 0(cluding antibody) for display aimed-at endocrine cell reactivity
08/23/2000CN1264385A Novel 2-(iminomethyl) amino-phenyl derivatives, preparation, application as medicines and compositions containing same
08/23/2000CN1264384A Fused 1,2,4-thiadiazine derivatives, their preparation method and use
08/23/2000CN1264381A 4-aminopyrrole (3,2-d) pyrimidines as neuropeptide Y receptor antagonists
08/23/2000CN1264377A Substituted pyrazoles as P38 kinase inhabitors
08/23/2000CN1264371A Pyrazine derivatives, their preparation and medicines containing them
08/23/2000CN1264370A Polyhydroxyalkylpyrazine derivatives, their preparation and medicines containing them
08/23/2000CN1264369A Polyhydroxyalkylpyrazine derivatives, their preparation and medicines containing them
08/23/2000CN1264368A Polyhydroxybutylpyrazines, their preparation and medicines containing them
08/23/2000CN1264321A Hydrogel composites and superporous hydrogel composites having fast swelling, high mechanical strenght, and superabsorbent properties
08/23/2000CN1264303A Treatment of diabetes with thiazolidinedione, insulin secretagogue and diguanide
08/23/2000CN1264302A Treatment of diabetes with thiazolidinedione and sulphonylurea
08/23/2000CN1263774A Organic trace elements supplement
08/23/2000CN1263772A Hypolipemic capsule
08/23/2000CN1055700C Therapeutic peptide derivatives
08/23/2000CN1055699C Sulfomycin analogue
08/23/2000CN1055697C Phospholipi derivatives containing higher elements of the Vth main group
08/23/2000CN1055684C Method for preparing substituted pyridine
08/22/2000USRE36832 N-heteroaryl-N'-phenylurea derivatives, their production and use
08/22/2000USRE36831 Iron-pyridone complexes for anemia
08/22/2000US6107331 Use of estrogen antagonists and estrogen agonists in inhibiting pathological conditions
08/22/2000US6107323 Preventing or treating angiotensin diseases by administering an antagonist and compound which increases insulin sensitivity
08/22/2000US6107315 Nervous system disorders
08/22/2000US6107310 Heteroarylcarboxamide derivatives for treating CNS disorders
08/22/2000US6107294 Nervous system and psychological disorders
08/22/2000US6107291 Antiinflammatory agent
08/22/2000US6107283 Antitumor agents; diabetic therapy
08/22/2000US6107274 Enzyme inhibitors as hypoglycemic agents in treatment of type-ii diabetes
08/22/2000US6107075 Human elastase IV
08/22/2000US6106874 Calcium fortified fruit beverages
08/22/2000US6106858 Loading active materials of liposomes by dissolving
08/22/2000US6106822 Hormone and growth factor phosphoglycokine mimetics from mycobacterium
08/22/2000CA2001754C Glucan dietary additives
08/17/2000WO2000047741A1 Glycosylated leptin compositions and related methods
08/17/2000WO2000047735A2 NON-HUMAN TRANSGENIC ANIMAL WHOSE GERM CELLS AND SOMATIC CELLS CONTAIN A KNOCKOUT MUTATION IN DNA ENCODING ORPHAN NUCLEAR RECEPTOR ERRalpha
08/17/2000WO2000047720A2 Pancreatic progenitor cells, methods and uses related thereto
08/17/2000WO2000047625A2 Humanized immunoglobulin reactive with b7 molecules and methods of treatment therewith
08/17/2000WO2000047619A1 Therapeutics and diagnostics based on an il-1b mutation
08/17/2000WO2000047602A1 33 human secreted proteins
08/17/2000WO2000047594A1 Novel gymnemic acid derivatives, process for the preparation thereof and use thereof as medicine
08/17/2000WO2000047580A2 Phenyl urea and phenyl thiourea derivatives
08/17/2000WO2000047577A1 Phenyl urea and phenyl thiourea derivatives as orexin receptor antagonists
08/17/2000WO2000047576A1 Cinnamide derivatives as orexin-1 receptors antagonists
08/17/2000WO2000047575A1 Pyrrole derivatives and cell death inhibitors
08/17/2000WO2000047568A2 1,2-benzothiazepines for the treatment of hyperlipidemic diseases
08/17/2000WO2000047562A1 Spirocyclic ketones and their use as tachykinin antagonists
08/17/2000WO2000047559A2 5-ht1f agonists
08/17/2000WO2000047552A1 Tyrosine alkoxyguanidines as integrin inhibitors
08/17/2000WO2000047238A1 Integration of transplanted neural progenitor cells into neural tissue of immature and mature dystrophic recipients
08/17/2000WO2000047219A2 Methods and reagents for treating glucose metabolic disorders
08/17/2000WO2000047213A1 Sitostanol formulation with emulsifier to reduce cholesterol absorption and method for preparing and use of same
08/17/2000WO2000047212A1 Quinazoline derivatives as angiogenesis inhibitors
08/17/2000WO2000047210A1 Use of 4-amino pyridine for treatment of peripheral neuropathies
08/17/2000WO2000047206A1 Use of pyrrolidine derivatives for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of obesity or appetite regulation
08/17/2000WO2000047194A2 METHODS OF TREATING C1s-MEDIATED DISEASES AND CONDITIONS, AND COMPOUNDS AND COMPOSITIONS THEREFOR
08/17/2000WO2000047104A2 Antagonists of hmg1 for treating inflammatory conditions
08/17/2000WO2000033837A3 Myt1 kinase inhibitors
08/17/2000WO2000027819A3 Antrhranilic acid amides and the use thereof as medicaments
08/17/2000WO2000021574A3 Site-directed dual pegylation of proteins
08/17/2000WO2000018912A3 Atp binding cassette genes and proteins for diagnosis and treatment of lipid disorders and inflammatory diseases
08/17/2000DE19906016A1 Zubereitung für oral zu verabreichende Nahrungsergänzungs- und/oder Arzneimittel in Form von Tabletten Preparation for oral nutritional supplements and / or drug in pill form
08/17/2000CA2362593A1 Pancreatic progenitor cells, methods and uses related thereto
08/17/2000CA2362592A1 Humanized immunoglobulin reactive with b7 molecules and methods of treatment therewith
08/17/2000CA2362372A1 Tyrosine alkoxyguanidines as integrin inhibitors
08/17/2000CA2362272A1 Spirocyclic ketones and their use as tachykinin antagonists
08/17/2000CA2362147A1 1,2-benzothiazepines for the treatment of hyperlipidemic diseases
08/17/2000CA2361293A1 33 human secreted proteins
08/17/2000CA2360324A1 Peptide yy (pyy) for inducing glucose responsiveness in pancreatic islets
08/17/2000CA2360233A1 Methods of treating c1s-mediated diseases and conditions, and compounds and compositions therefor
08/17/2000CA2360164A1 5-ht1f agonists
08/17/2000CA2360103A1 Non-human transgenic animal whose germ cells and somatic cells contain a knockout mutation in dna encoding orphan nuclear receptor erralpha
08/17/2000CA2359926A1 Antagonists of hmg1 for treating inflammatory conditions
08/16/2000EP1028111A1 Amide derivatives or salts thereof
08/16/2000EP1027893A2 Alginate containing medicament and implant for treating fibrosis
08/16/2000EP1027891A2 Neuropeptide y antagonists
08/16/2000EP1027890A2 Homer a new target of treating psychiatric disorders
08/16/2000EP1027887A2 Matrix controlled release device
08/16/2000EP1027438A2 Novel cytokine receptors
08/16/2000EP1027363A2 Adenosine a1-receptor agonists
08/16/2000EP1027070A1 Conjugate heat shock protein-binding peptides
08/16/2000EP1027069A1 Compositions and methods for treating lysosomal storage disease
08/16/2000EP1027058A1 Disaccharide derivatives for treating hyperglycaemia
08/16/2000EP1027056A1 Alpha-ketoamide multicatalytic protease inhibitors
08/16/2000EP1027045A1 Methods and compositions for regulation of 5-alpha reductase activity
08/16/2000EP1027037A1 Pharmaceutical preparation comprising clodronate as active ingredient and silicified microcrystalline cellulose as excipient
08/16/2000CN1263534A A preparation derived from shark cartilage for treatment of diseases related to excessive PHF or excessive intracellular calcium
08/16/2000CN1263528A N-triazolyl-2-indolecarboxamides and their use as CCK-A agonists
08/16/2000CN1263468A Polyallylamine polymers for treating hypercholesterolemia
08/16/2000CN1263467A Treatment of diabetes with thiazolidinedione, insulin secretagogue and alpha glucocidase inhibitor
08/16/2000CN1263095A New tricycloacylamide compound, its preparation method and medicinal composition containing them
08/16/2000CN1262934A Medicine for curing diseases of cardiovascular system and cerebrovascular sytsem
08/16/2000CN1262931A Method for extracting marine active substance and its application
08/16/2000CN1055402C Capsule for curing diabets mellitus
08/15/2000US6103936 Reacting aldehyde, sulfide, sulfone, or sulfoxide with formamide in presence of acid catalyst, and optionally a dehydrating agent
08/15/2000US6103910 D-proline derivatives
08/15/2000US6103874 Human KDEL receptor
08/15/2000US6103742 Administering to said patient a therapeutically effective amount of an insulin sensitivity enhancer in combination with a statin compound to treat diabetes
08/15/2000US6103737 Aryl- and arylamino- substituted heterocycles as corticotropin releasing hormone antagonists
1 ... 1097 1098 1099 1100 1101 1102 1103 1104 1105 1106 1107 1108 1109 1110 1111 1112 1113 1114 1115 1116 1117 ... 1298